Suzhou Zelgen Biopharmaceuticals Co., Ltd. (SHA:688266)
China flag China · Delayed Price · Currency is CNY
100.40
+0.98 (0.99%)
Apr 29, 2026, 3:00 PM CST

SHA:688266 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Cash & Equivalents
2,0312,1542,110797.051,137
Upgrade
Trading Asset Securities
-40.5137.02248.9365.26
Upgrade
Cash & Short-Term Investments
2,0312,1942,2471,0461,202
Upgrade
Cash Growth
-7.43%-2.34%114.79%-12.97%-24.86%
Upgrade
Accounts Receivable
154.25143.63101.1488.9962.37
Upgrade
Other Receivables
10.279.3810.8912.5112.45
Upgrade
Receivables
164.52153.01112.03101.574.82
Upgrade
Inventory
173.27182.86110.8598.9851.91
Upgrade
Other Current Assets
74.1345.8550.7945.377.33
Upgrade
Total Current Assets
2,4432,5762,5201,2921,406
Upgrade
Property, Plant & Equipment
485.89363.43271.21247.09188.91
Upgrade
Long-Term Investments
--5.991010
Upgrade
Other Intangible Assets
30.5950.0169.2791.03116.29
Upgrade
Long-Term Deferred Charges
5.9811.3916.3920.9613.03
Upgrade
Other Long-Term Assets
3.633.884.027.4811.78
Upgrade
Total Assets
2,9693,0052,8871,6681,746
Upgrade
Accounts Payable
244.16197.1137.73151.72118.19
Upgrade
Accrued Expenses
89.5286.2282.0267.548.22
Upgrade
Short-Term Debt
989.05951.86795.16390.79131.81
Upgrade
Current Portion of Long-Term Debt
42.14.9750.5650.0430.03
Upgrade
Current Portion of Leases
9.0111.213.1713.6913.55
Upgrade
Current Income Taxes Payable
13.9720.9520.6420.2918.58
Upgrade
Current Unearned Revenue
1.25--0.280.36
Upgrade
Other Current Liabilities
38.88101.1535.8934.8820.16
Upgrade
Total Current Liabilities
1,4281,3731,135729.19380.89
Upgrade
Long-Term Debt
8444.35-50.09-
Upgrade
Long-Term Leases
8.626.8629.4643.1848.18
Upgrade
Long-Term Unearned Revenue
8.079.211.5545.0448.05
Upgrade
Long-Term Deferred Tax Liabilities
1.645.79.5813.3215.77
Upgrade
Other Long-Term Liabilities
358.49292.4556.6--
Upgrade
Total Liabilities
1,8891,7521,242880.82492.88
Upgrade
Common Stock
264.71264.71264.71240240
Upgrade
Additional Paid-In Capital
3,1093,1203,3532,2222,205
Upgrade
Retained Earnings
-2,280-2,117-1,979-1,700-1,243
Upgrade
Comprehensive Income & Other
-14.05-14.47-5.95-2.84-6.32
Upgrade
Total Common Equity
1,0801,2541,633759.121,196
Upgrade
Minority Interest
--1.2611.9828.3756.76
Upgrade
Shareholders' Equity
1,0801,2531,645787.491,253
Upgrade
Total Liabilities & Equity
2,9693,0052,8871,6681,746
Upgrade
Total Debt
1,1331,039888.35547.8223.57
Upgrade
Net Cash (Debt)
898.421,1551,358498.18978.32
Upgrade
Net Cash Growth
-22.21%-14.97%172.65%-49.08%-36.78%
Upgrade
Net Cash Per Share
3.424.365.312.084.08
Upgrade
Filing Date Shares Outstanding
264.71264.71264.71264.49240
Upgrade
Total Common Shares Outstanding
264.71264.71264.71240240
Upgrade
Working Capital
1,0151,2021,385562.571,025
Upgrade
Book Value Per Share
4.084.746.173.164.98
Upgrade
Tangible Book Value
1,0501,2041,564668.091,080
Upgrade
Tangible Book Value Per Share
3.974.555.912.784.50
Upgrade
Buildings
138.34135.2641.9341.9341.21
Upgrade
Machinery
158.18145.53120.48121.7496.02
Upgrade
Construction In Progress
275.93123.47135.8386.6727.25
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.